Home › Calculator › MTVA Dividend Calculator 2026
MTVA Dividend DRIP Calculator 2026
117.65% YieldHealthcareMetaVia Inc. · NASDAQ
Price: $1.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MTVA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MTVA snowball 📈
$10,000 in MTVA → $23.85M in 10 years · $1,074,422.40/month
About MetaVia Inc. (MTVA) — Dividend Analysis 2026
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Compare MTVA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MTVA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MTVA position with:
🌍 MTVA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MTVA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 94.12% | 91.32% | $9,412 / yr |
| 🇬🇧 UK ISA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇬🇧 UK Taxable | 8.75% | 107.36% | 104.56% | $10,736 / yr |
| 🇨🇦 TFSA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇨🇦 CA Taxable | 25% | 88.24% | 85.44% | $8,824 / yr |
| 🇦🇺 Super (pension) | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇦🇺 AU Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
| 🇩🇪 DE Taxable | 26.375% | 86.62% | 83.82% | $8,662 / yr |
| 🇫🇷 FR Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MTVA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MTVA Dividend Payment Schedule
MTVA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MTVA vs Healthcare Benchmarks
How MTVA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MTVA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MTVA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-06-08 | 17,186 | — | — | ||
| A-Award | 2026-01-23 | 28,000 | — | — | ||
| A-Award | 2026-01-23 | 32,000 | — | — | ||
| G-Gift | 2025-08-12 | 14,200 | — | — | ||
| A-Award | 2025-06-30 | 28,147 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MTVA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
MetaVia Inc. (MTVA) is currently trading at $1.70, 94% below its 52-week high. The current dividend yield is 117.65% based on an annual payout of $2.00 per share.
MTVA (MetaVia Inc.) — 117.65% Dividend Yield Analysis
MetaVia Inc. (MTVA) is a healthcare stock currently trading at $1.70 with a dividend yield of 117.65%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (117.65%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.